News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Merck & Co., Inc., AstraZeneca PLC Ally on Cancer Therapy
June 15, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Merck & Co. is teaming with AstraZeneca Plc to test two cancer drugs as a single therapy, leading a wave of alliances among rivals spurred by new evidence that multiple genetic triggers can lead to tumor growth.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
AstraZeneca
Merck & Co.
MORE ON THIS TOPIC
Earnings
Sarepta says to ‘exercise prudence’ in setting expectations for Elevidys’ recovery
May 7, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
May 6, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales
May 6, 2026
·
4 min read
·
Annalee Armstrong
Business
CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026
May 6, 2026
·
1 min read
·
Gabrielle Masson
